Journey Medical Corp (DERM)
Healthcare
Drug Manufacturers - Specialty & Generic
6.50 $
+1.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Journey Medical Corp (DERM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31 | -48 | -74 | -104 | -213 | 9.0 | 5.1 | -2.2 | -14 | 5.2 | -9.1 | -12 | |
| 0.0 | 0.1 | 0.1 | 0.3 | 0.6 | 1.3 | 1.5 | 2.6 | 4.4 | 3.9 | 3.4 | 4.7 | |
| 1.6 | 5.1 | 11 | 21 | 30 | 0.2 | 0.2 | 2.5 | 4.4 | 2.6 | 6.1 | 6.3 | |
| – | – | – | – | – | 0.7 | 0.6 | 22 | – | – | – | – | |
| -1.5 | 98 | 58 | 202 | -154 | 3.5 | -2.2 | 15 | 6.2 | -1.7 | -3.8 | -12 | |
| 0.2 | 0.2 | 0.8 | 0.3 | 0.6 | 2.4 | 1.2 | 10 | 20 | 5.0 | 15 | 0.0 | |
| -109 | -2.6 | -130 | -104 | -13 | -2.4 | -1.2 | -10 | -20 | -5.0 | -15 | – | |
| – | – | – | – | – | – | – | 1.6 | 0.4 | – | – | – | |
| 170 | 105 | 139 | 184 | 2.1 | – | – | -1.6 | -0.4 | – | – | – | |
| – | – | – | – | – | -3.6 | -0.5 | 5.1 | 17 | -4.5 | 17 | 16 | |
| 174 | 103 | 139 | 463 | 35 | -3.6 | -0.5 | 53 | 16 | -4.8 | 17 | 16 | |
| 11 | 52 | -65 | 254 | -191 | 3.1 | 3.4 | 41 | -17 | -4.6 | -7.1 | 3.8 | |
| -32 | -49 | -75 | -104 | -214 | 6.6 | 3.9 | -12 | -34 | 0.2 | -9.1 | -12 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.